PT86426A - Dispositivo resiliente para a administracao de um medicamento por via transdermica, e dispositivos empregando esteres/eteres de acidos gordos de alcanodiois como estimuladores da absorcao percutanea - Google Patents
Dispositivo resiliente para a administracao de um medicamento por via transdermica, e dispositivos empregando esteres/eteres de acidos gordos de alcanodiois como estimuladores da absorcao percutaneaInfo
- Publication number
- PT86426A PT86426A PT86426A PT8642687A PT86426A PT 86426 A PT86426 A PT 86426A PT 86426 A PT86426 A PT 86426A PT 8642687 A PT8642687 A PT 8642687A PT 86426 A PT86426 A PT 86426A
- Authority
- PT
- Portugal
- Prior art keywords
- transdermmic
- percutaneal
- estimulators
- alcanodious
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94535686A | 1986-12-22 | 1986-12-22 | |
US4179387A | 1987-04-23 | 1987-04-23 | |
US7980187A | 1987-07-30 | 1987-07-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
PT86426A true PT86426A (pt) | 1989-01-17 |
PT86426B PT86426B (pt) | 1994-03-31 |
Family
ID=27365979
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT86426A PT86426B (pt) | 1986-12-22 | 1987-12-21 | Dispositivo resiliente para a administracao de um medicamento por via transdermica, e dispositivos empregando esteres/eteres de acidos gordos de alcanodiois como estimuladores da absorcao percutanea |
PT101320A PT101320B (pt) | 1986-12-22 | 1993-07-27 | Dispositivo resiliente para administracao de um medicamento por via transdermica e processo para a preparacao de uma composicao farmaceutica para administracao de um medicamento por via transdermica |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT101320A PT101320B (pt) | 1986-12-22 | 1993-07-27 | Dispositivo resiliente para administracao de um medicamento por via transdermica e processo para a preparacao de uma composicao farmaceutica para administracao de um medicamento por via transdermica |
Country Status (8)
Country | Link |
---|---|
EP (2) | EP0272987B1 (pt) |
JP (2) | JPH0816054B2 (pt) |
AT (1) | ATE124256T1 (pt) |
AU (2) | AU601528B2 (pt) |
CA (1) | CA1309021C (pt) |
DE (2) | DE3785015T2 (pt) |
ES (2) | ES2039471T3 (pt) |
PT (2) | PT86426B (pt) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4588580B2 (en) * | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
US4818540A (en) * | 1985-02-25 | 1989-04-04 | Rutgers, The State University Of New Jersey | Transdermal fertility control system and process |
US5560922A (en) * | 1986-05-30 | 1996-10-01 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process |
US4906463A (en) * | 1986-12-22 | 1990-03-06 | Cygnus Research Corporation | Transdermal drug-delivery composition |
AU607172B2 (en) * | 1986-12-22 | 1991-02-28 | Cygnus, Inc. | Diffusion matrix for transdermal drug administration |
AU627163B2 (en) * | 1987-11-13 | 1992-08-20 | Landec Labs, Inc. | Temperature-controlled active agent dispenser |
US4906475A (en) * | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
US5223261A (en) * | 1988-02-26 | 1993-06-29 | Riker Laboratories, Inc. | Transdermal estradiol delivery system |
EP0402407B1 (en) * | 1988-02-26 | 1994-08-03 | Riker Laboratories, Inc. | Transdermal estradiol delivery system |
US4994278A (en) * | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Breathable backing |
FR2635979B1 (fr) * | 1988-09-07 | 1992-05-29 | Lhd Lab Hygiene Dietetique | Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee |
JPH02233621A (ja) * | 1989-03-07 | 1990-09-17 | Nikken Chem Co Ltd | 経皮吸収促進剤及びこれを含有する医薬外用製剤 |
US5059426A (en) * | 1989-03-22 | 1991-10-22 | Cygnus Therapeutic Systems | Skin permeation enhancer compositions, and methods and transdermal systems associated therewith |
US5053227A (en) * | 1989-03-22 | 1991-10-01 | Cygnus Therapeutic Systems | Skin permeation enhancer compositions, and methods and transdermal systems associated therewith |
US4973468A (en) * | 1989-03-22 | 1990-11-27 | Cygnus Research Corporation | Skin permeation enhancer compositions |
US5252335A (en) * | 1989-07-12 | 1993-10-12 | Cygnus Therapeutic Systems | Transdermal administration of lisuride |
US5124157A (en) * | 1989-08-18 | 1992-06-23 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
AU647109B2 (en) * | 1989-10-23 | 1994-03-17 | Theratech, Inc.(Incorporated under the laws of the State of Delaware) | Iontophoresis device and method using a rate-controlling membrane |
CA2028256A1 (en) * | 1989-10-23 | 1991-04-24 | Bahram Farhadieh | Multiple layer transdermal drug administration system |
US5069909A (en) * | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
GB9021674D0 (en) * | 1990-10-05 | 1990-11-21 | Ethical Pharma Ltd | Transdermal device |
TW218849B (pt) * | 1991-05-17 | 1994-01-11 | Bristol Myers Squibb Co | |
US5229130A (en) * | 1991-12-20 | 1993-07-20 | Cygnus Therapeutics Systems | Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems |
US5358715A (en) * | 1992-09-02 | 1994-10-25 | Cygnus Therapeutic Systems | Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters |
US6024974A (en) * | 1995-01-06 | 2000-02-15 | Noven Pharmaceuticals, Inc. | Composition and methods for transdermal delivery of acid labile drugs |
IL116539A (en) * | 1995-01-06 | 2002-02-10 | Noven Pharma | Preparations given through the skin of unstable anti-acid drugs |
US5785991A (en) * | 1995-06-07 | 1998-07-28 | Alza Corporation | Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate |
FR2735024B1 (fr) * | 1995-06-08 | 1997-11-28 | Sanofi Sa | Dispositif d'administration cutanee d'un produit medicamenteux ou cosmetique. |
FR2749586B1 (fr) * | 1996-06-11 | 1998-08-07 | Hoechst Marion Roussel Inc | Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments |
ES2244422T3 (es) * | 1999-04-01 | 2005-12-16 | Alza Corporation | Dispositivos para la administracion transdermica de farmacos que comprenden un deposito de poliuretano para farmacos. |
DE10012908B4 (de) * | 2000-03-16 | 2005-03-17 | Lts Lohmann Therapie-Systeme Ag | Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
IT1318705B1 (it) * | 2000-09-22 | 2003-08-27 | Gianluigi Ciocca | Medicamento transdermico ad alta penetrazione. |
US20020119187A1 (en) * | 2000-09-29 | 2002-08-29 | Cantor Adam S. | Composition for the transdermal delivery of fentanyl |
DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
WO2004024155A1 (ja) * | 2002-09-13 | 2004-03-25 | Hisamitsu Pharmaceutical Co., Inc. | 貼付剤 |
TWI296531B (en) * | 2002-10-18 | 2008-05-11 | Hisamitsu Pharmaceutical Co | Transdermal adhesive preparations for topical administration of fentanyl |
US20050202073A1 (en) * | 2004-03-09 | 2005-09-15 | Mylan Technologies, Inc. | Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
US8383149B2 (en) | 2005-09-23 | 2013-02-26 | Alza Corporation | High enhancer-loading polyacrylate formulation for transdermal applications |
US9056061B2 (en) | 2005-09-23 | 2015-06-16 | Alza Corporation | Transdermal nicotine salt delivery system |
PT2450041T (pt) | 2005-10-12 | 2018-11-16 | Unimed Pharmaceuticals Llc | Gel de testosterona melhorado e método para a sua utilização |
EP2295046B1 (de) * | 2009-09-14 | 2012-12-19 | Acino AG | Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon |
EP2599478A1 (de) | 2011-11-30 | 2013-06-05 | Acino AG | Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon |
US20130338122A1 (en) * | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
BR112016020738B1 (pt) * | 2014-03-11 | 2023-04-11 | Dupont Nutrition Usa, Inc | Composição de liberação controlada e método |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2352553A1 (fr) * | 1976-05-25 | 1977-12-23 | Bailly Pierre | Procede pour l'administration de produits actifs a action medicamenteuse locale et support permettant la mise en oeuvre de ce procede |
DE2755224A1 (de) * | 1976-12-15 | 1978-07-13 | Procter & Gamble | Schmerzen und entzuendungen linderndes mittel zur oertlichen anwendung |
DE2902414A1 (de) † | 1979-01-23 | 1980-08-07 | Hoechst Ag | Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung |
US4233295A (en) * | 1979-05-31 | 1980-11-11 | E. R. Squibb & Sons, Inc. | Corticosteroid formulations containing sebacate carrier |
JPS579714A (en) * | 1980-06-19 | 1982-01-19 | Nitto Electric Ind Co Ltd | Drug member |
CA1165240A (en) † | 1980-07-09 | 1984-04-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
US4435180A (en) * | 1982-05-25 | 1984-03-06 | Alza Corporation | Elastomeric active agent delivery system and method of use |
JPS5984817A (ja) * | 1982-11-08 | 1984-05-16 | Sekisui Chem Co Ltd | 薬剤徐放性製剤 |
JPS59227819A (ja) * | 1983-06-09 | 1984-12-21 | Nitto Electric Ind Co Ltd | 消炎、鎮痛用貼付製剤 |
JPS60155113A (ja) * | 1984-01-24 | 1985-08-15 | Teika Seiyaku Kk | 経皮吸収薬剤 |
US4588580B2 (en) * | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
US4626539A (en) * | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
US4568343A (en) * | 1984-10-09 | 1986-02-04 | Alza Corporation | Skin permeation enhancer compositions |
JPS61210024A (ja) * | 1985-03-14 | 1986-09-18 | Yamanouchi Pharmaceut Co Ltd | 外用塩酸ニカルジピン製剤 |
JPS61249934A (ja) * | 1985-04-27 | 1986-11-07 | Nitto Electric Ind Co Ltd | 外皮投与用組成物 |
-
1987
- 1987-12-14 AU AU82498/87A patent/AU601528B2/en not_active Ceased
- 1987-12-21 ES ES198787402945T patent/ES2039471T3/es not_active Expired - Lifetime
- 1987-12-21 PT PT86426A patent/PT86426B/pt not_active IP Right Cessation
- 1987-12-21 DE DE87402945T patent/DE3785015T2/de not_active Expired - Lifetime
- 1987-12-21 AT AT92100183T patent/ATE124256T1/de not_active IP Right Cessation
- 1987-12-21 DE DE3751383T patent/DE3751383T3/de not_active Expired - Lifetime
- 1987-12-21 EP EP87402945A patent/EP0272987B1/en not_active Expired - Lifetime
- 1987-12-21 EP EP92100183A patent/EP0483105B2/en not_active Expired - Lifetime
- 1987-12-21 ES ES92100183T patent/ES2075966T3/es not_active Expired - Lifetime
- 1987-12-22 CA CA000555141A patent/CA1309021C/en not_active Expired - Lifetime
- 1987-12-22 JP JP62325099A patent/JPH0816054B2/ja not_active Expired - Lifetime
-
1990
- 1990-06-27 AU AU57845/90A patent/AU640383B2/en not_active Ceased
-
1993
- 1993-07-27 PT PT101320A patent/PT101320B/pt not_active IP Right Cessation
-
1995
- 1995-08-07 JP JP7201228A patent/JP2535731B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE3785015T2 (de) | 1993-10-07 |
EP0272987B1 (en) | 1993-03-24 |
CA1309021C (en) | 1992-10-20 |
DE3751383T2 (de) | 1996-01-11 |
AU601528B2 (en) | 1990-09-13 |
EP0483105B1 (en) | 1995-06-28 |
DE3751383T3 (de) | 2001-07-05 |
ATE124256T1 (de) | 1995-07-15 |
JPH0840937A (ja) | 1996-02-13 |
PT86426B (pt) | 1994-03-31 |
JP2535731B2 (ja) | 1996-09-18 |
DE3785015D1 (de) | 1993-04-29 |
PT101320B (pt) | 2001-06-29 |
AU5784590A (en) | 1990-11-01 |
EP0483105B2 (en) | 2001-01-17 |
ES2039471T3 (es) | 1993-10-01 |
ES2075966T3 (es) | 1995-10-16 |
EP0483105A1 (en) | 1992-04-29 |
DE3751383D1 (de) | 1995-08-03 |
EP0272987A3 (en) | 1988-08-24 |
JPS63233916A (ja) | 1988-09-29 |
JPH0816054B2 (ja) | 1996-02-21 |
AU8249887A (en) | 1988-06-23 |
EP0272987A2 (en) | 1988-06-29 |
PT101320A (pt) | 1994-07-29 |
AU640383B2 (en) | 1993-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT86426A (pt) | Dispositivo resiliente para a administracao de um medicamento por via transdermica, e dispositivos empregando esteres/eteres de acidos gordos de alcanodiois como estimuladores da absorcao percutanea | |
PT90240A (pt) | Processo para a preparacao de composicoes laminares para a administracao transdermica de fentanil | |
ES2041238T3 (es) | Matriz de difusion para la administracion de medicamento por via percutanea y dispositivo de administracion de medicamento por via percutanea que los incluye. | |
DK433584D0 (da) | Middel til transdermal applikation af stoffer, der er virksomme som laegemidler | |
DE3879853D1 (de) | Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien. | |
FI92014C (fi) | Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi | |
ES2027720T3 (es) | Emplastos conteniendo sustancias activas para la administracion controlada de sustancias activas a traves de la piel. | |
HUT75251A (en) | Pharmaceutical dosage form for transdermal administration | |
ES2016620B3 (es) | Sistema para liberar medicamentos con bioaceptabilidad mejorada. | |
ES2059312T3 (es) | Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion. | |
DE3381164D1 (de) | Gebisshaftmittel mit karayagummi auf einer hydrophilen grundlage. | |
IT8722501A0 (it) | Formulazioni farmaceutiche per somministrazione transdermica. | |
EP0235259A4 (en) | NOVEL TRANSDERMAL PHARMACEUTICAL DOSAGE UNIT AGAINST ANGINES AND ITS ADMINISTRATION METHOD. | |
DK131586A (da) | Transdermalt, antiallergisk, farmaceutisk praeparat | |
DE3773322D1 (de) | Pharmazeutische zubereitungen mit heilender aktivitaet. | |
ES271205Y (es) | Dispositivo para la carga-descarga de jeringas hipodermicas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Patent granted, date of granting |
Effective date: 19930927 |
|
MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20080927 |